Table II.
Vascular function variables in 70 SSc patients at follow-up FMD | Difference between SSc patients with DU (n=32) and those without DU (n=38) | p value |
---|---|---|
Baseline flow | −17.2 ± 6.9 | 0.01 |
Absolute FMD | −.03 ± .04 | 0.50 |
Normalised absolute FMD | 0.00007 ± .00006 | 0.25 |
Relative FMD | −0.7 ± 1.3 | 0.58 |
Normalised relative FMD | −0.002 ± 0.002 | 0.33 |
Shear Rate | −5013 ± 3238 | 0.12 |
Peak Hyperemia | 31.0 ± 36 | 0.39 |
Vascular resistance | 0.57 ± 0.34 | 0.09 |
Change in Baseline flow* | −40.8 ± 12.9 | 0.002 |
Normalised Absolute FMD change* | −0.00007 | .30 |
Absolute FMD change* | −0.002 ± 0.05 | 0.96 |
Relative FMD change* | −0.3 ± 1.53 | 0.84 |
Normalised Relative FMD change* | −0.002 ± .002 | 0.3 |
FMD Shear Rate change* | −14374 ± 4037 | 0.0001 |
FMD Peak Hyperaemia change* | −33.8 ± 37.7 | 0.36 |
Normalised FMD change* | −0.00002 ± 0.00004 | 0.57 |
Change between measures at baseline FMD adjusted for days between measures and duration of SSc.